Oragenics Receives European Union CPNP Notifications for ProBiora3® Cosmetic Tablets

[Business Wire] – Oragenics, Inc. , today announced its ProBiora3® tablets intended to freshen breath, whiten teeth and contribute to overall oral health has successfully completed an independent third party review of its Cosmetic Product Safety Report. more

View todays social media effects on OGEN

View the latest stocks trending across Twitter. Click to view dashboard

See who Oragenics is hiring next, click here to view